Feed Anticoccidials Market Research Report by Consumption (Injection and Oral), Type, Form, Livestock, Source, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19
New York, May 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Feed Anticoccidials Market Research Report by Consumption, Type, Form, Livestock, Source, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06258223/?utm_source=GNW The Global Feed Anticoccidials Market size was estimated at USD 354.91 million in 2021 and expected to reach USD 372.00 million in 2022, and is projected to grow at a CAGR 4.99% to reach USD 475.47 million by 2027. Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period. Market Segmentation & Coverage: This research report categorizes the Feed Anticoccidials to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Consumption, the market was studied across Injection and Oral. Based on Type, the market was studied across DOT, Diclazuril, Lasalocid, Monensin, Narasin, Nicarbazin, and Salinomycin. Based on Form, the market was studied across Dry and Liquid. Based on Livestock, the market was studied across Poultry, Ruminants, and Swine. Based on Source, the market was studied across Chemical and Natural. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market. Cumulative Impact of 2022 Russia Ukraine Conflict: We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia. This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Feed Anticoccidials market considering the current update on the conflict and its global response. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Feed Anticoccidials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Feed Anticoccidials Market, including Bayer AG, Bioproperties Pty Ltd, Boehringer Ingelheim International GmbH., Ceva Animal Health, LLC, Elanco Animal Health Inc., Huvepharma Inc., Impextraco NV, Kemin Industries Inc., Merck Animal Health, Phibro Animal Health Corporation., Qilu Animal Health Products Co., Ltd., Vetoquinol S.A., Virbac S.A, Zoetis Inc, and Zydus Animal Health Ltd.. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Feed Anticoccidials Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Feed Anticoccidials Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Feed Anticoccidials Market? 4. What is the competitive strategic window for opportunities in the Global Feed Anticoccidials Market? 5. What are the technology trends and regulatory frameworks in the Global Feed Anticoccidials Market? 6. What is the market share of the leading vendors in the Global Feed Anticoccidials Market? 7. What modes and strategic moves are considered suitable for entering the Global Feed Anticoccidials Market? Read the full report: https://www.reportlinker.com/p06258223/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
Meanwhile, things are even worse for the growth-dependent Nasdaq Composite (NASDAQINDEX: ^IXIC). Following its all-time high in November 2021, the Nasdaq has tumbled 27%. The Nasdaq's tumble officially places it in a bear market.
A Friday rally saves the S&P 500 from a technical bear market, but leaves questions hanging: How long will this last, and will it end in recession?
Entering the final day of trading this week, the stock of Chinese electric vehicle maker Nio (NYSE: NIO) had been down more than 12% just this week, and more than 25% over the past month. After rising more than 9% Friday morning, Nio American depositary shares (ADSs) were still up 7.1% as of 10:50 a.m. ET. There are fears the U.S.-listed ADSs could be delisted as the company joined a growing list of Chinese names that will be required to provide proof of meeting U.S. accounting and audit standards for three straight years.
Feel poorer after the S&P 500's sell-off? Just know it could be worse. Much worse. Investors who piled in some $40 billion firms found out.
(Bloomberg) -- An investment firm for the Walton family ramped up its position in a U.S. municipal bond fund and added a sizable stake in Japanese equities, while also betting on small-cap stocks and Coinbase Global Inc. before tumultuous declines. Most Read from BloombergElon Musk Sows Doubt Over His $44 Billion Twitter TakeoverIndia Bans Wheat Exports as Food Security Comes Under ThreatSony PlayStation Staff Fume Over CEO’s Abortion CommentsApple Testing iPhones That Ditch Lightning Ports in F
In this article, we will discuss the 12 best energy stocks for 2022. If you want to skip our detailed analysis of the energy sector which highlights key trends and major players, you can go directly to 5 Best Energy Stocks for 2022. The energy sector has been the biggest contributor to skyrocketing inflation in […]
Warren Buffett has guided Berkshire Hathaway to market-crushing returns through good times and bad, and the Oracle of Omaha's investment conglomerate has now posted a total return of roughly 3.5% year to date. With a tip of the hat to Buffett's impressive market-beating mojo, a panel of Motley Fool investors has identified a trio of great stocks in the Berkshire portfolio that have what it takes to deliver fantastic performance. Read on to see why they identified Amazon (NASDAQ: AMZN), Kroger (NYSE: KR), and Apple (NASDAQ: AAPL) as stocks that can help you crush the market over the long term.
Unity Software's (NYSE: U) stock price plunged 29% during after-hours trading on May 10 following its first-quarter earnings report. On a non-generally accepted accounting principles (non-GAAP) basis, Unity narrowed its net loss from $27.3 million to $25.4 million, or $0.08 per share -- which matched analysts' expectations. For the second quarter, Unity expects its revenue to rise just 6% to 8% year over year, which broadly misses the consensus forecast for 31% growth.
Where do millionaires keep their money? High net worth individuals put money into different classifications of financial and real assets, including stocks, mutual funds, retirement accounts and real estate. Most of the 20.27 million millionaires in the U.S. did not … Continue reading → The post Where Do Millionaires Keep Their Money? appeared first on SmartAsset Blog.
Friday's mini-rally notwithstanding, it’s getting ugly out there. Bottom line: The market may shoot back up anytime, but this doesn’t feel like a plain-vanilla dip
Valuations are falling to their lowest levels in years, creating an excellent opportunity to buy the dip.
Stock market crashes and corrections happen. A bear market of at least a 20% decline will also eventually happen again, maybe even this month. St. Louis Fed president James Bullard said it's a "fantasy" to believe the worst inflation the U.S. has experienced in 40 years could be tamed by tiptoeing around it.
(Bloomberg) -- The week is ending on a higher note for Big Tech on hopes a relentless selloff may be nearing exhaustion. But Friday’s rally can’t completely wipe out a sobering signal from Apple Inc. shares. Most Read from BloombergElon Musk Sows Doubt Over His $44 Billion Twitter TakeoverIndia Bans Wheat Exports as Food Security Comes Under ThreatSony PlayStation Staff Fume Over CEO’s Abortion CommentsApple Testing iPhones That Ditch Lightning Ports in Favor of USB-CTerra $45 Billion Face Plant
After reaching $3 trillion in November, the market value of the crypto market has fallen to $1.37 trillion.
These blue chip stocks can generate steady passive income in even the most challenging environments.
A $10,000 investment back then would be worth around $11.7 million today. It's fair to ask whether the kind of growth needed to mint new millionaires from an investment in the e-commerce giant is still possible. Amazon's stock has lost 40% of its value from its all-time high and is down over 30% in 2022 alone as pressure on consumers from rampant inflation, higher costs, and a deteriorating economy takes a toll.
Tesla (TSLA) CEO Elon Musk’s early Friday morning tweet proclaiming his $44 billion bid to buy Twitter (TWTR) is on hold may violate laws meant to protect public markets from manipulation, experts say.
'We prefer companies that have strong free cash flow or distribute cash to shareholders,' Bank of America said.
The departing executives said he was asked to leave by the CEO, who "wants to take the team in a different direction."
Shell trades at a discount to its U.S.-based peers, despite its attractive assets. A breakup or dividend hike could help to narrow the valuation gap.